PRECIGEN, INC. (PGEN)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenues | 856 | - | - | - |
| Selling, general and administrative | 16,133 | - | - | - |
| Research and development | 11,488 | - | - | - |
| Impairment of other noncurrent assets | - | - | - | - |
| Impairment of goodwill | 3,907 | - | - | - |
| Cost of products and services-Service | 1,092 | - | - | - |
| Total operating expenses | 32,620 | - | - | - |
| Operating loss | -31,764 | - | - | - |
| Other (expense) income, net | -31 | - | - | - |
| Interest income | 696 | - | - | - |
| Interest expense | - | - | - | - |
| Change in fair value of warrant liabilities | 4,460 | - | - | - |
| Total other (expense) income, net | 5,125 | - | - | - |
| Loss before income taxes-Segment Continuing Operations | -26,639 | - | - | - |
| Income Tax Expense Benefit | 3 | - | - | - |
| Income tax (expense) benefit | 3 | - | 12 | -1,689 |
| Total revenues | - | 1,341 | 66 | 31 |
| Impairment of other noncurrent assets | - | - | - | 32,915 |
| Impairment of goodwill | - | - | - | 1,630 |
| Selling, general and administrative | - | 12,359 | 9,836 | 10,306 |
| Research and development | - | 10,478 | 11,370 | 15,693 |
| Cost of products and services | - | 1,100 | 1,009 | 1,014 |
| Total operating expenses | - | 23,937 | 22,215 | 61,558 |
| Operating loss | - | -22,596 | -21,262 | -60,841 |
| Other income, net | - | 7 | -2,985 | 43 |
| Interest income | - | 918 | 283 | 319 |
| Interest expense | - | 1 | 2 | 2 |
| Change in fair value of warrant liabilities | - | -32,481 | - | - |
| Total other (expense) income, net | - | -31,557 | -2,704 | 360 |
| Loss before income taxes | - | -54,153 | -23,966 | -60,481 |
| Net loss | -26,642 | -54,153 | -23,978 | -58,792 |
| Net loss per share, basic (in dollars per share) | -0.09 | -0.18 | -0.09 | -0.23 |
| Net loss per share, diluted (in dollars per share) | -0.09 | -0.18 | -0.09 | -0.23 |
| Weighted average shares outstanding, basic (in shares) | 296,434,726 | 293,879,653 | 275,881,170 | 252,366,533 |
| Weighted average shares outstanding, diluted (in shares) | 296,434,726 | 293,879,653 | 275,881,170 | 252,366,533 |